| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
|---|
| 07/21/1993 | EP0551308A1 Novel peptide antigens and immunoassays, test kits and vaccines using the same |
| 07/21/1993 | EP0551304A1 Fungicidally active compounds |
| 07/20/1993 | US5229367 Prostaglandin inhibitor, phospholipase inhibitor |
| 07/20/1993 | US5229364 Polypeptides derived from the human immunodeficiency virus endonuclease protein |
| 07/20/1993 | US5229363 Cyclic hexapeptide compounds |
| 07/20/1993 | CA1320350C Combination lock for blood identification system |
| 07/18/1993 | CA2087379A1 Pseudopeptidic derivatives having an antigonistic activity for bradykinine, process for their preparation and pharmaceutical compositions containing them |
| 07/16/1993 | CA2087328A1 Therapeutically active peptides and pseudopeptides derivatives in the blood coagulation process, a process for their preparation and pharmaceutical compositions containing them |
| 07/14/1993 | EP0550500A1 NUCLEOTIDE AND AMINO ACID SEQUENCES OF PROTEIN MTP40 OF $i(M. TUBERCULOSIS) AND SYNTHETIC PEPTIDES DERIVED THEREFROM |
| 07/13/1993 | US5227467 Containing fluorinated valine residue |
| 07/13/1993 | US5227294 Method of producing surfactin with the use of mutant of bacillus subtilis |
| 07/08/1993 | WO1993013218A1 Endothelin-antagonizing peptide |
| 07/08/1993 | WO1993013127A1 Peptides immunochemically reactive with antibodies directed against hepatitis non-a, non-b virus |
| 07/08/1993 | WO1993013126A1 Peptide compounds having therapeutic activity |
| 07/08/1993 | WO1993013089A1 Macrocyclic polyether carboxylic acids |
| 07/08/1993 | WO1993012819A1 Protein- and peptide-metal ion pharmaceutical applications |
| 07/08/1993 | WO1993012810A1 Pharmaceutical pentapeptide compositions and methods of use thereof |
| 07/08/1993 | WO1993012139A1 A novel molecule which inhibits neuropeptide tyrosine biological function |
| 07/08/1993 | CA2127275A1 Pharmaceutical pentapeptide compositions and methods of use thereof |
| 07/08/1993 | CA2126693A1 Peptides immunochemically reactive with antibodies directed against hepatitis non-a, non-b virus |
| 07/08/1993 | CA2126236A1 Peptide compounds having therapeutic activity |
| 07/08/1993 | CA2126212A1 A novel molecule which inhibits neuropeptide tyrosine biological function |
| 07/08/1993 | CA2104952A1 Endothelin-antagonizing peptide |
| 07/07/1993 | EP0380554B1 Vasoactive peptides |
| 07/06/1993 | US5225531 Hexapeptide Lys Gly Ala Gly Asp Val |
| 07/06/1993 | US5225528 Controlling premature labor |
| 07/06/1993 | US5225400 Immunostimulating peptides, a process for their preparation and pharmaceutical compositions containing them |
| 07/06/1993 | US5225399 Antimicrobial amphiphilic peptides |
| 07/06/1993 | US5225193 Bordetella toxin peptides and vaccines |
| 06/30/1993 | EP0548825A1 Bradykinin-antagonists for the treatment of acute pancreatitis |
| 06/30/1993 | EP0548234A1 Cloning of chicken anaemia dna |
| 06/30/1993 | EP0548217A1 Process for the preparation of c-terminally amidated peptides. |
| 06/30/1993 | CN1073719A Nanbv diagnostics and vaccines |
| 06/30/1993 | CN1073684A Polypeptide analogues having growth hormone releasing activity |
| 06/30/1993 | CN1073603A Anetic kinin antagon for curing acute pancreatitis |
| 06/29/1993 | US5223487 Tri-, tetra-, penta- and hexapeptatides of Asp, Gly, Lys, Ser, Ala and salts |
| 06/29/1993 | US5223485 Anaphylatoxin-receptor ligands |
| 06/29/1993 | US5223484 Dodecapeptide containing cysteine, histidine, arginine, lysine, glycine, tyrosine, alanine, aspartic acid, leucine |
| 06/29/1993 | US5223481 Biologically active lipoprotein and its use |
| 06/29/1993 | US5223427 Synthetic polypeptide |
| 06/28/1993 | CA2086162A1 Oligonucleotides, oligopeptides and determination system of hcv antibody subtype |
| 06/28/1993 | CA2086079A1 Peptide, production and use thereof |
| 06/25/1993 | CA2086142A1 Prolyl endopeptidase inhibitor |
| 06/24/1993 | WO1993012140A1 Peptide with cell adhesion activity and polymeric modification thereof |
| 06/24/1993 | WO1993011796A1 Further improvements relating to the radiolabelling of proteins |
| 06/24/1993 | WO1993011789A1 Modified position (7) bradykinin antagonist peptides |
| 06/24/1993 | WO1993011783A1 Composition and treatment with biologically active peptides and chelating agents |
| 06/24/1993 | WO1993011781A1 Synthetic compounds and compositions with enhanced cell binding |
| 06/24/1993 | CA2125975A1 Further improvements relating to the radiolabelling of proteins |
| 06/24/1993 | CA2125494A1 Composition and treatment with biologically active peptides and chelating agents |
| 06/23/1993 | EP0547689A2 Synthetic peptides comprising a cyclic HIV principal neutralizing determinant and a T-cell stimulatory epitope |
| 06/23/1993 | EP0547681A2 Synthetic peptides comprising a cyclic HIV principal neutralizing determinant and a lipopeptide |
| 06/23/1993 | EP0272278B1 $i(D)-GL CONJUGATE THERAPY |
| 06/22/1993 | US5221789 Interferon-gamma receptor fragment and its production |
| 06/22/1993 | US5221752 α-keto amide derivatives |
| 06/22/1993 | US5221664 Inhibiting growth of a target cell or virus |
| 06/20/1993 | CA2058876A1 Cyclic hiv principal neutralizing determinant peptides |
| 06/19/1993 | WO1994004568A1 Peptide inhibitors of inflammation mediated by selectins |
| 06/19/1993 | CA2104099A1 Peptide inhibitors of inflammation mediated by selectins |
| 06/19/1993 | CA2085084A1 Synthetic peptides comprising a cyclic hiv principal neutralizing determinant and a t-cell stimulatory epitope |
| 06/19/1993 | CA2085083A1 Synthetic peptides comprising a cyclic hiv principal neutralizing determinant and a lipopeptide |
| 06/16/1993 | EP0547029A1 Immunogen and its use for preparing antibodies to HbA1c |
| 06/16/1993 | EP0546101A1 METHOD OF INTERFERING WITH FORMATION OF $g(a)-ANTICHYMOTRYPSIN-$g(b)-PROTEIN COMPLEX AND SYNTHETIC PEPTIDES FOR USE THEREIN |
| 06/16/1993 | EP0546077A1 Cd18 peptide medicaments for the treatment of disease |
| 06/16/1993 | EP0546068A1 Bioactive egf peptides for promotion of tissue regeneration and cancer therapy |
| 06/16/1993 | EP0545991A1 Peptides that block human immunodeficiency virus infections and methods of use thereof |
| 06/15/1993 | US5219985 Antifungal agent |
| 06/10/1993 | WO1993011231A1 Tools for the diagnosis and treatment of alzheimer's disease |
| 06/10/1993 | WO1993011162A1 Bispecific antibody heterodimers |
| 06/10/1993 | WO1993011156A1 Heparin- and sulfatide-binding peptides from the type i repeats of human thrombospondin |
| 06/10/1993 | WO1993011155A1 Fragments of prion proteins |
| 06/10/1993 | WO1993011154A1 Inhibitors of the conversion of big endothelin to endothelin |
| 06/10/1993 | WO1993011153A1 Peptides and antibodies for treatment of rheumatoid arthritis |
| 06/10/1993 | WO1993011152A1 New peptide derivatives |
| 06/10/1993 | WO1993011120A1 Compounds, compositions and methods for binding bio-affecting substances to surface membranes of bio-particles |
| 06/10/1993 | WO1993010807A1 Hemoregulatory peptides |
| 06/10/1993 | WO1993010805A1 Inhibitory immunoglobulin polypeptides to human pdgf beta receptor |
| 06/10/1993 | WO1993010747A2 TECHNETIUM-99m LABELED PEPTIDES FOR IMAGING |
| 06/10/1993 | CA2125298A1 Tools for the diagnosis and treatment of alzheimer's disease |
| 06/10/1993 | CA2124202A1 Hemoregulatory peptides |
| 06/10/1993 | CA2123894A1 Bispecific antibody heterodimers |
| 06/10/1993 | CA2123694A1 Peptides and antibodies for treatment of rheumatoid arthritis |
| 06/09/1993 | EP0545554A2 Antibodies specific for RAR-gamma or a specific isoform of RAR-gamma |
| 06/09/1993 | EP0545198A2 Peptides with insulin like activity |
| 06/09/1993 | EP0544861A1 Immunoassay for non-a non-b hepatitis |
| 06/09/1993 | EP0544860A1 Novel biologically active peptide compositions and uses therefor |
| 06/09/1993 | EP0544838A1 Non-a, non-b hepatitis virus antigen, diagnostic methods and vaccines |
| 06/09/1993 | EP0544815A1 Peptides from the GMP-140 lectinbindingdomain and selectin binding ligands on carbonhydrates |
| 06/09/1993 | EP0500695A4 Gnrh analogs |
| 06/09/1993 | EP0463070B1 A process for producing pentapeptides and intermediates for use in the synthesis |
| 06/09/1993 | EP0368920B1 Lectines fixing beta-d-galactoside |
| 06/09/1993 | EP0134242B1 Protective peptide antigen |
| 06/08/1993 | US5218089 Retro-inverso analogues of thymopentin and the method for their synthesis |
| 06/08/1993 | US5217956 Composition and treatment with biologically active peptides and certain anions |
| 06/08/1993 | US5217955 Treating colon, prostate or breast cancer in mammals |
| 06/08/1993 | US5217953 Vasoactive intestinal peptide antagonist |
| 06/08/1993 | US5217952 Peptides WS-9326a and WS-9326b, derivatives thereof and uses thereof |
| 06/08/1993 | US5217869 Screening methodes to obtain antibodies to use in immunoassay |
| 06/08/1993 | CA1318986C Inhibition of mineral deposition by polyanionic/hydrophobic peptides and derivatives thereof |
| 06/01/1993 | US5215964 Treating aging, depression, anxiety, autoimmune diseases |